239 related articles for article (PubMed ID: 16585551)
1. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes.
Every AL; Kramer DR; Mannering SI; Lew AM; Harrison LC
J Immunol; 2006 Apr; 176(8):4608-15. PubMed ID: 16585551
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
4. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.
Martinez NR; Augstein P; Moustakas AK; Papadopoulos GK; Gregori S; Adorini L; Jackson DC; Harrison LC
J Clin Invest; 2003 May; 111(9):1365-71. PubMed ID: 12727928
[TBL] [Abstract][Full Text] [Related]
5. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
Glinka Y; Chang Y; Prud'homme GJ
Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
[TBL] [Abstract][Full Text] [Related]
6. Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sites.
Solvason N; Lou YP; Peters W; Evans E; Martinez J; Ramirez U; Ocampo A; Yun R; Ahmad S; Liu E; Yu L; Eisenbarth G; Leviten M; Steinman L; Garren H
J Immunol; 2008 Dec; 181(12):8298-307. PubMed ID: 19050246
[TBL] [Abstract][Full Text] [Related]
7. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
8. Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.
Sarikonda G; Sachithanantham S; Manenkova Y; Kupfer T; Posgai A; Wasserfall C; Bernstein P; Straub L; Pagni PP; Schneider D; Calvo TR; Coulombe M; Herold K; Gill RG; Atkinson M; Nepom G; Ehlers M; Staeva T; Garren H; Steinman L; Chan AC; von Herrath M
PLoS One; 2013; 8(2):e54712. PubMed ID: 23405091
[TBL] [Abstract][Full Text] [Related]
9. (Pro)insulin-specific regulatory T cells.
Harrison LC; Solly NR; Martinez NR
Novartis Found Symp; 2003; 252():132-41; discussion 141-5, 203-10. PubMed ID: 14609216
[TBL] [Abstract][Full Text] [Related]
10. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin.
Zhang W; Jin H; Hu Y; Yu Y; Li X; Ding Z; Kang Y; Wang B
Hum Gene Ther; 2010 Feb; 21(2):171-8. PubMed ID: 19788384
[TBL] [Abstract][Full Text] [Related]
11. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
12. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.
Calderon B; Suri A; Pan XO; Mills JC; Unanue ER
J Immunol; 2008 Nov; 181(10):6964-74. PubMed ID: 18981116
[TBL] [Abstract][Full Text] [Related]
17. Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.
Griffin AC; Zhao W; Wegmann KW; Hickley WF
Am J Pathol; 1995 Sep; 147(3):845-57. PubMed ID: 7545875
[TBL] [Abstract][Full Text] [Related]
18. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
Li A; Ojogho O; Franco E; Baron P; Iwaki Y; Escher A
Vaccine; 2006 Jun; 24(23):5036-46. PubMed ID: 16621191
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
